Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide C pseudogene 5 (SNRPCP5) is a human pseudogene related to the SNRPC gene, which encodes a protein component of the spliceosomal small nuclear ribonucleoproteins (snRNPs). Pseudogenes are typically non-functional sequences derived from parent genes and do not produce functional proteins. SNRPCP5 is annotated in genomic databases but lacks evidence of a protein product, clear expression profiles, or biological roles. There are no known links to disease, biomarkers, or therapeutic relevance for this pseudogene. It should not be confused with functional snRNP protein-coding genes or those pseudogenes with demonstrated regulatory or ceRNA activity. The closest analogous example is SNRPFP1 (a pseudogene of SNRPF), which in hepatocellular carcinoma acts via a long non-coding RNA transcript to sponge miR-126-5p and promote cancer growth. However, there is no published evidence of such a role for SNRPCP5 specifically. Pseudogenes can sometimes have important regulatory lncRNA activity, but this is not currently supported for this target. If you intended a different, protein-coding component of the small nuclear ribonucleoproteins (such as SNRPC), there would be substantial biological detail, as these are core elements of the spliceosome complex involved in pre-mRNA splicing. SNRPCP5, however, is a non-coding pseudogene, not a canonical target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 5 (SNRPCP5).